Received May 13, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Discomfort in the area where the patient previously had shingles; This non-serious case was reported by a other health professional via sales rep and described the occurrence of discomfort in a female patient who received Herpes zoster (Shingrix) for an unknown indication. The patient's past medical history included shingles and vesicular rash. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced discomfort (Verbatim: Discomfort in the area where the patient previously had shingles). The outcome of the discomfort was resolved (duration 24 hrs). It was unknown if the reporter considered the discomfort to be related to Shingrix. It was unknown if the company considered the discomfort to be related to Shingrix. Additional Information: GSK Receipt Date: 01-JAN-2025 The reporter did not know dose number of Shingrix vaccine. The batch number was not provided and a request for this information has been made.
Medical History/Concurrent Conditions: Shingles; Vesicular rash